Drugmaker Boehringer Settles Marketing Claim for $95 Million: U.S.

Boehringer Ingelheim Pharmaceuticals Inc agreed to pay $95 million to U.S. government agencies to settle civil allegations that it illegally marketed drugs for unapproved uses, the U.S. Justice Department said.
Reuters